-
-
-
-
-
-
-
Mizuho's Jared Holz: 'We still like the sector, despite some recent setbacks like QURE and others'
-
-
-
-
-
-
-
uniQure BV (QURE) PT Lowered to $35 at Leerink Partners
-
-
-
-
-
-
-
Stifel: 'We can see why QURE shares are lower on CNBC comments from FDA'
-
-
-
-
-
-
-
uniQure (QURE) Reiterated at Overweight by Cantor Fitzgerald: FDA Feedback Key
-
-
-
-
-
-
-
uniQure BV (QURE) PT Lowered to $60 at Leerink Partners
-
-
-
-
-
-
-
uniQure (QURE) halted on volatility
-
-
-
-
-
-
-
uniQure BV (QURE) PT Raised to $80 at Cantor Fitzgerald
-
412,617 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

